1. Death due to Heart failure (HF) progression: Death occurring in the context of clinically worsening symptoms and/or signs of heart failure. New or worsening signs and/or symptoms of congestive HF may include any of the following:
 New or increasing symptoms and/or signs of HF requiring the initiation of, or an increase in, treatment directed at HF or occurring in a patient already receiving maximal therapy for HF  HF symptoms or signs requiring continuous intravenous therapy or oxygen administration  Cardiogenic shock, manifested as clinical signs and symptoms of hypoperfusion felt to be secondary to cardiac dysfunction, and not occurring in the context of an acute myocardial infarction or as the consequence of a primary arrhythmic event Patients who are hospitalized and are being actively treated for HF and who have an arrhythmia as the terminal event will be classified as having a HF-related death.
Sudden cardiac death:
Death that occurs unexpectedly in a previously stable patie nt will be adjudicated as being sudden cardiac death. The death can be further catego rized as witnessed or unwitnessed:
Witnessed sudden cardiac death:

Witnessed within 60 minutes of the onset of new or worsening cardiac symptoms  Witnessed and attributed to an identified arrhythmia (e.g., captured on an electrocardiographic (ECG) recording or witnessed on a monitor by either a medic or paramedic)  Subjects unsuccessfully resuscitated from cardiac arrest or successfully resuscitated from cardiac arrest but who die without identification of a non-cardiac etiology Note that if a witnessed sudden cardiac death occurs as a complication of another primary cardiac process, eg, cardiogenic shock or acute myocardial infarction, the primary process should be adjudicated as the cause of death.
Unwitnessed sudden cardiac death:
An unwitnessed death is one that occurs in a patient who when last seen alive within an observation period of 72 hours:  Did not manifest another life-threatening non-cardiac disease (e.g., infectious, metabolic disorders); and/or  Did not reveal a cause other than cardiovascular (e.g., trauma) at the scene of death; and/or  Death was ruled cardiovascular in cause on an autopsy report or death certificate, and occurred in the absence of pre-existing circulatory failure or other modes of death. Tables   Table S1 . Specific diseases entity of the main underlying etiology of acute heart failure, ischemic heart disease. * Ischemic heart disease was defined as a proven coroanry artery stenosis that can clinically explain the pathophysology of heart failure, with no other plausible explanation. SBP, systolic blood pressure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; OR, odds ratio; HR, Hazard ratio; CRP, C-reactive protein; BMI, body mass index; LVEF, left ventricular ejection fraction. SBP, systolic blood pressure; LV, left ventricle; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; OR, odds ratio; HR, Hazard ratio. BMI, body mass index; LVEF, left ventricular ejection fraction; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft surgery; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; CVA, cerebrovascular accident; WBC, white blood cell; Hb, hemoglobin; Na; sodium; BUN, blood urea nitrogen; CRP, C-reactive protein; BUN, brain natriuretic peptide; NTproBNP, n-terminal Brain natriuretic peptide. * smoking: current smoker / ex-smoker / never smoker. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; BSA, body surface area; LVEF, left ventricular ejection fraction; CK-MB, creatine kinase-muscle/brain; WBC, white blood cell; Hb, hemoglobin; Na; sodium; K, potassium; RDW, red cell distribution width; TG, triglyceride; HDL, high-density lipoproteins; BUN, blood urea nitrogen; cTNI, cardiac troponin-I; CRP, C-reactive protein; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft surgery; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; CVA, cerebrovascular accident; NYHA, New York Heart Association; NTproBNP, n-terminal Brain natriuretic peptide; SMD, standardized mean difference. Figure   Figure S1 . Detailed cause of in-hospital clinical events.
Death due to

Ischemic heart disease*
Supplementary
In-hospital clinical events occurred in 280 (5.1%) of the cases during admission. Cardiac death occupied the majority of in-hospital clinical events (70.3%), and the most common cause of cardiac death was HF aggravation (60.4% 
